Giulio Francolini
University of Florence, Azienda Ospedaliero-Universitaria Careggi
Papers
4
Total Citations
113
H-Index
4
About
Giulio Francolini is a leading radiation oncologist whose research centers on the application of advanced stereotactic body radiotherapy (SBRT) and robotic radiosurgery for treating recurrent and oligometastatic cancers. His major contributions lie in demonstrating the feasibility and efficacy of non-invasive, high-precision retreatment for patients with limited disease spread, particularly in challenging anatomical sites. His most cited work, a 2017 study on robotic stereotactic retreatment for recurrent prostate cancer (50 citations), established a critical salvage strategy for patients who have exhausted conventional radiation options. Francolini further advanced the field with the phase II ROCK trial (NCT03520894, 29 citations), pioneering a preoperative robotic radiosurgery approach for early breast cancer that precisely targets a well-defined tumor volume before surgery. His expertise extends to treating liver oligometastases from colorectal cancer and optimizing treatment planning systems for robotic SBRT. With over 100 cumulative citations across his key papers, Francolini’s work is instrumental in refining stereotactic techniques to expand curative-intent options for patients with limited metastatic burden, directly influencing clinical protocols in radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4